BR112023026370A2 - Peptídeo pendente de ligação ao ghr e composição que compreende o mesmo - Google Patents

Peptídeo pendente de ligação ao ghr e composição que compreende o mesmo

Info

Publication number
BR112023026370A2
BR112023026370A2 BR112023026370A BR112023026370A BR112023026370A2 BR 112023026370 A2 BR112023026370 A2 BR 112023026370A2 BR 112023026370 A BR112023026370 A BR 112023026370A BR 112023026370 A BR112023026370 A BR 112023026370A BR 112023026370 A2 BR112023026370 A2 BR 112023026370A2
Authority
BR
Brazil
Prior art keywords
ghr
composition
same
pendant
binding peptide
Prior art date
Application number
BR112023026370A
Other languages
English (en)
Inventor
Haruaki Kurasaki
Katsuma Matsui
Masataka Umitsu
Tatsuya Tomiyama
Yoshiaki Masuda
Original Assignee
Peptidream Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptidream Inc filed Critical Peptidream Inc
Publication of BR112023026370A2 publication Critical patent/BR112023026370A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

peptídeo pendente de ligação ao ghr e composição que compreende o mesmo. a presente invenção refere-se, de modo geral, a peptídeos que se ligam ao receptor do hormônio do crescimento (ghr), a peptídeos que se ligam ao ghr e possuem atividade antagonista, e a composições compreendendo tais peptídeos.
BR112023026370A 2021-06-18 2022-06-17 Peptídeo pendente de ligação ao ghr e composição que compreende o mesmo BR112023026370A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163212596P 2021-06-18 2021-06-18
PCT/JP2022/024395 WO2022265109A1 (en) 2021-06-18 2022-06-17 Ghr-binding pending peptide and composition comprising same

Publications (1)

Publication Number Publication Date
BR112023026370A2 true BR112023026370A2 (pt) 2024-03-05

Family

ID=82492839

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023026370A BR112023026370A2 (pt) 2021-06-18 2022-06-17 Peptídeo pendente de ligação ao ghr e composição que compreende o mesmo

Country Status (9)

Country Link
US (1) US20230012823A1 (pt)
EP (1) EP4355760A1 (pt)
KR (1) KR20240045202A (pt)
CN (1) CN117677628A (pt)
AU (1) AU2022294601A1 (pt)
BR (1) BR112023026370A2 (pt)
CA (1) CA3222510A1 (pt)
IL (1) IL309196A (pt)
WO (1) WO2022265109A1 (pt)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525491A (en) 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
CA2434237C (en) 2000-12-07 2012-05-15 Eli Lilly And Company Glp-1 fusion proteins
SE0300959D0 (sv) 2002-12-19 2003-04-02 Pharmacia Ab Methods for predicting therapeutic response to agents acting on the growth hormone receptor
NZ586034A (en) * 2004-02-02 2011-10-28 Ambrx Inc Modified human growth hormone polypeptides and their uses
JP5119444B2 (ja) 2005-12-06 2013-01-16 国立大学法人 東京大学 多目的アシル化触媒とその用途
WO2011064668A2 (en) * 2009-11-30 2011-06-03 Centro De Investigacion Y De Estudios Avanzados Del Plants that reproduce via unreduced gametes
JP5818237B2 (ja) 2010-09-09 2015-11-18 国立大学法人 東京大学 Ｎ−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法
JPWO2014119600A1 (ja) 2013-01-30 2017-01-26 ペプチドリーム株式会社 ＦｌｅｘｉｂｌｅＤｉｓｐｌａｙ法
EP2970506A1 (en) 2013-03-11 2016-01-20 Novo Nordisk Health Care AG Growth hormone compounds

Also Published As

Publication number Publication date
WO2022265109A1 (en) 2022-12-22
KR20240045202A (ko) 2024-04-05
CA3222510A1 (en) 2022-12-22
IL309196A (en) 2024-02-01
CN117677628A (zh) 2024-03-08
EP4355760A1 (en) 2024-04-24
AU2022294601A1 (en) 2023-12-14
AU2022294601A9 (en) 2024-01-04
US20230012823A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
IL270743A (en) Monoclonal antibodies to lymphocyte-associated protein - Tcytotoxic 4 (CTLA-4), preparations containing them and their uses
CO6150201A2 (es) Anticuerpo humanizado contra beta amiloide
NZ756763A (en) Engineered transferrin receptor binding polypeptides
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
PE20110306A1 (es) Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3)
MX2021012216A (es) Degradadores de transductores de señal y activadores de transcripción (stat) y usos de los mismos.
MX2022000252A (es) Compuestos que comprenden un ligando de proteina de activacion de fibroblasto y uso del mismo.
BR112021024938A2 (pt) Anticorpos de receptor 1 de peptídeo natriurético e métodos de uso
MY194682A (en) Formulation
DE69231918D1 (de) Peptidantagonisten des bradykinin
MX2020008125A (es) Composiciones que comprenden berberina.
EA202092508A1 (ru) Составы на основе антител к pd-l1 человека
MX2022010621A (es) Anticuerpos anti-cd19 humano.
BR112023026370A2 (pt) Peptídeo pendente de ligação ao ghr e composição que compreende o mesmo
MX2019009759A (es) Composiciones de peptido estables.
AR003693A1 (es) Composiciones y metodos para el control de hongos nocivos.
ES2123556T3 (es) Peptidos de tipo bradiquinina.
MX2023008423A (es) Anticuerpos anti-gremlin1 novedosos.
MX2023003973A (es) Degradadores de transductores de señales y activadores de la transcripción (stat) y usos de los mismos.
MX2022011437A (es) Degradadores de transductores de se?al y activadores de la transcripcion (stat) y usos de los mismos.
WO2020235974A3 (ko) 단일염기 치환 단백질 및 이를 포함하는 조성물
CL2020002459A1 (es) Variantes de anticuerpo c-terminales
BR112023024837A2 (pt) Anticorpos anti-ccr8
EP3771719A8 (en) A peptide binding to tau-protein
BR112022005357A2 (pt) Composição, e, artigo